Myocardial perfusion reserve and contractile pattern after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy

被引:7
|
作者
Slart, R. H. J. A. [1 ,4 ]
Tio, R. A. [2 ,4 ]
van der Vleuten, P. A. [2 ]
Willems, T. P. [3 ]
Lubbers, D. D. [3 ]
Dierckx, R. A.
van Veldhuisen, D. J. [2 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, NL-9700 RB Groningen, Netherlands
[2] Univ Med Ctr Groningen, Dept Cardiol, NL-9713 AV Groningen, Netherlands
[3] Univ Med Ctr Groningen, Dept Radiol, NL-9713 AV Groningen, Netherlands
[4] Univ Med Ctr Groningen, Cardiovasc Imaging Grp Groningen, NL-9713 AV Groningen, Netherlands
关键词
Left ventricular function; cardiomyopathy; PET imaging; magnetic resonance imaging; DOBUTAMINE STRESS ECHOCARDIOGRAPHY; LEFT-VENTRICULAR FUNCTION; HEART-FAILURE; BLOOD-FLOW; EJECTION FRACTION; PROGNOSTIC VALUE; PET; IMPROVEMENT; METOPROLOL; ISCHEMIA;
D O I
10.1007/s12350-010-9216-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In Idiopathic Dilated Cardiomyopathy (IDC) an imbalance between myocardial oxygen consumption and supply has been postulated. The ensuing subclinical myocardial ischemia may contribute to progressive deterioration of LV function. beta-blocker is the therapy of choice in these patients. However, not all patients respond to the same extent. The aim of this study was to elucidate whether differences between responders and non-responders can be identified with respect to regional myocardial perfusion reserve (MPR) and contractile performance. Patients with newly diagnosed IDC underwent Positron Emission Tomography (PET) scanning using both (13)N-ammonia as a perfusion tracer (baseline and dipyridamole stress), and (18)F-fluoro-deoxyglucose as a metabolism tracer, and a dobutamine stress MRI. MRI and PET were repeated 6 months after maximal beta-blocker therapy. MPR (assessed by PET) as well as wall motion score (WMS, assessed by MRI) were evaluated in a 17 segment-model. Functional response to beta-blocker therapy was assigned as a stable or improved LVEF or diminished LVEF. Sixteen patients were included (age 47.9 +/- A 11.5 years; 12 males, LVEF 28.6 +/- A 8.4%). Seven patients showed improved LVEF (9.7 +/- A 3.1%), and nine patients did not show improved LVEF (-3.4 +/- A 3.9%). MPR improved significantly in responders (1.56 +/- A .23 to 1.93 +/- A .49, P = .049), and MPR decreased in non-responders; however, not significantly (1.98 +/- A .70 to 1.61 +/- A .28, P = .064), but was significantly different between both groups (P = .017) after beta-blocker therapy. A significant correlation was found between change in perfusion reserve and change in LVEF: a decrease in perfusion reserve was associated with a decrease in LVEF and vice versa. Summed rest score of wall motion in responders improved from 26 to 21 (P = .022) whereas in non-responders no change was observed from 26 to 25) (P = ns). Summed stress score of wall motion in responders improved from 23 to 21 (P = .027) whereas in non-responders no change was observed from 27 to 26) (P = ns). In IDC patients, global as well as regional improvement after initiation of beta-blocker treatment is accompanied by an improvement in regional perfusion parameters. On the other hand in IDC patients with further left ventricular function deterioration after initiation of beta-blocker therapy this is accompanied by a decrease in perfusion reserve.
引用
收藏
页码:479 / 485
页数:7
相关论文
共 50 条
  • [31] Myocardial texture analysis in idiopathic dilated cardiomyopathy:: Prediction of contractile reserve on dobutamine echocardiography
    Dagdeviren, B
    Akdemir, O
    Bolca, O
    Eren, M
    Gürlertop, Y
    Tezel, T
    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2002, 15 (01) : 36 - 42
  • [32] Gated myocardial SPECT to predict response to a blocker therapy in patients with idiopathic dilated cardiomyopathy.
    Fukuchi, K
    Ishida, Y
    Miyatake, K
    Hayashida, K
    Yasumura, Y
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 180P - 180P
  • [33] Effect of a new beta-blocker, nipradilol, on cardiac function and neurohumoral factors in idiopathic dilated cardiomyopathy
    Yoshikawa, T
    Handa, S
    Akaishi, M
    Mitamura, H
    Ogawa, S
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1996, 60 (05): : 285 - 292
  • [34] Changes in left atrial chamber size predicts response to beta-blocker therapy in patients with dilated cardiomyopathy
    Ryoke, T
    Ando, M
    Itagaki, K
    Muro, A
    Hisamatsu, Y
    Hitsumoto, T
    Kobayashi, S
    Sada, K
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (09) : S301 - S301
  • [35] HEMODYNAMICS AND LEFT-VENTRICULAR FUNCTION IN PATIENTS WITH DILATED CARDIOMYOPATHY AFTER THE NEW BETA-BLOCKER RIDAZOLOL
    HAERER, W
    HENZE, E
    STAUCH, M
    HERZ, 1988, 13 (01) : 54 - 58
  • [36] IS IT POSSIBLE TO PREDICT THE RESPONSE TO BETA-BLOCKER TREATMENT IN DILATED CARDIOMYOPATHY
    LARDIERI, G
    DILENARDA, A
    SINAGRA, G
    ZECCHIN, M
    PERKAN, A
    SECOLI, G
    RAKAT, S
    GREGORI, D
    CAMERINI, F
    CIRCULATION, 1994, 90 (04) : 66 - 66
  • [37] beta-Blocker use in systolic heart failure and dilated cardiomyopathy
    Hash, TW
    Prisant, LM
    JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (01): : 7 - 19
  • [38] Beta-blocker therapy induces ventricular resynchronization in dilated cardiomyopathy with narrow QRS complex
    Takemoto, Yasuhiko
    Hozumi, Takeshi
    Sugioka, Kenichi
    Takagi, Yasuhiro
    Matsumura, Yoshiki
    Yoshiyama, Minoru
    Abraham, Theodore P.
    Yoshikawa, Junichi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (07) : 778 - 783
  • [39] ROLE OF BETA-ADRENERGIC RECEPTORS IN BETA-BLOCKER THERAPY FOR CHRONIC HEART-FAILURE IN PATIENTS WITH DILATED CARDIOMYOPATHY
    KAGIYA, T
    HORI, M
    FUKUNAMI, M
    HOKI, N
    IWAKURA, K
    KURIHARA, T
    WATANABE, Y
    KAMADA, T
    CIRCULATION, 1987, 76 (04) : 308 - 308
  • [40] Beta-Blocker Therapy After Myocardial Infarction: Is There an Expiry Date?
    Qamar, Arman
    Bangalore, Sripal
    CANADIAN JOURNAL OF CARDIOLOGY, 2020, 36 (10) : 1577 - 1579